June Sherie Almenoff's Net Worth

$11.7 Million

Estimate Recalculated Jul 16, 2024 03:25PM EST

Who is June Sherie Almenoff?

June Sherie Almenoff has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include BRAINSTORM CELL THERAPEUTICS INC., TENAX THERAPEUTICS, INC., Avalo Therapeutics, Inc., Ohr Pharmaceutical Inc, INNOVATE BIOPHARMACEUTICALS, INC., and Furiex Pharmaceuticals, Inc..

SEC CIK

June Sherie Almenoff's CIK is 0001492647

Past Insider Trading and Trends

2014 was June Sherie Almenoff's most active year for acquiring shares with 9 total transactions. June Sherie Almenoff's most active month to acquire stocks was the month of January. 2014 was June Sherie Almenoff's most active year for disposing of shares, totalling 12 transactions. June Sherie Almenoff's most active month to dispose stocks was the month of January. 2014 saw June Sherie Almenoff paying a total of $1,469,418.02 for 126,013 shares, this is the most they've acquired in one year. In 2014 June Sherie Almenoff cashed out on 393,708 shares for a total of $13,271,220.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Snapshot price: $0.3717

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.00%
2K
—
—
6K
Dec 15
Form 4
+100.00%
2K
—
—
4K
Dec 10
Form 4
∞
2K
—
—
2K
Dec 12
Form 4
+25.88%
1.48K
$3.39
$5,000.25
7.17K
Jan 4
Form 4/A
∞
5.7K
$3.50
$19,950.00
5.7K
Mar 15
Form 4
∞
5.7K
$3.50
$19,950.00
5.7K
Mar 15
Form 3
—
0
—
—
0
No matching records found

TENAX THERAPEUTICS, INC. (TENX) Snapshot price: $11.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 10
No matching records found

Avalo Therapeutics, Inc. (AVTX) Snapshot price: $4.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 30
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Nov 10
Form 3
—
0
—
—
0
No matching records found

Ohr Pharmaceutical Inc (NBSE) Snapshot price: $0.670101

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 16
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Mar 10
Form 4
+55.05%
6K
$6.75
$40,500.00
16.9K
Feb 6
Form 4
+1.75%
2.2K
$8.08
$17,780.00
127.57K
Sep 2 - Sep 3
Form 4
+2.62%
3.2K
$8.34
$26,688.00
125.37K
Jun 26
Form 4
+4.71%
5.5K
$10.25
$56,375.00
122.17K
Apr 8
Form 3
—
0
—
—
0
No matching records found

INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001

COO and Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.4K
$4.92
$6,885.18
1.4K
Aug 24 - Aug 27
Form 3
—
0
—
—
0
No matching records found